Amphiphysin autoimmunity: paraneoplastic accompaniments. - Wikidata - wikimedia - TriplyDB

Amphiphysin autoimmunity: paraneoplastic accompaniments.

Amphiphysin autoimmunity: paraneoplastic accompaniments.

http://www.wikidata.org/entity/Q45130801

about

'Medusa-head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 1: Anti-mGluR1, anti-Homer-3, anti-Sj/ITPR1 and anti-CARP VIII Spinal-generated movement disorders: a clinical review 'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 2: Anti-PKC-gamma, anti-GluR-delta2, anti-Ca/ARHGAP26 and anti-VGCC Autoimmune encephalitis update Need for a paradigm shift in therapeutic approaches to CNS injury Neuronal central nervous system syndromes probably mediated by autoantibodies Autoimmune encephalitis in psychiatric institutions: current perspectives Autoimmune stiff person syndrome and related myelopathies: understanding of electrophysiological and immunological processes.Childhood onset of stiff-man syndrome.Autoimmune encephalopathies.Autoimmune chorea in adults.Paraneoplastic neuromyelitis optica spectrum disorder associated with metastatic carcinoid expressing aquaporin-4 Rhombencephalitis / brainstem encephalitis.Investigation of the KIR4.1 potassium channel as a putative antigen in patients with multiple sclerosis: a comparative study.Autoimmune epilepsy: clinical characteristics and response to immunotherapy Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies.Current approaches to the treatment of paraneoplastic encephalitis.Paraneoplastic disorders The Etiological Spectrum of Acute Sensory Myelitis Paraneoplastic and non-paraneoplastic autoimmunity to neurons in the central nervous system Prevalence of HCV Infections and Co-Infection With HBV and HIV and Associated Risk Factors Among Addicts in Drug Treatment Centers, Lorestan Province, Iran.Movement disorders in paraneoplastic and autoimmune disease.Neuronal autoantigens--pathogenesis, associated disorders and antibody testing Paraneoplastic and other autoimmune disorders of the central nervous system.Stiff-person syndrome with amphiphysin antibodies: distinctive features of a rare disease.Clinical and Immunologic Investigations in Patients With Stiff-Person Spectrum Disorder The differential diagnosis of longitudinally extensive transverse myelitis.Paraneoplastic encephalomyelopathies: pathology and mechanisms.Longitudinal extensive transverse myelitis--it's not all neuromyelitis optica.Pathogenic and physiological autoantibodies in the central nervous system.Neural antigen-specific autoimmune disorders.Stiff-person syndrome: insights into a complex autoimmune disorder.Treatable causes of cerebellar ataxia.Microtubule-associated protein 1B: Novel paraneoplastic biomarker.Antineuronal autoantibodies in neurological disorders.Paraneoplastic neuromyelitis optica spectrum disorders: three new cases and a review of the literature.Differences in epileptic symptoms depending on the type of autoimmune-mediated limbic encephalitis.Autoimmune Movement Disorders: a Clinical and Laboratory Approach.Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System.Paraneoplastic neurologic syndrome: A practical approach.

P2860

Q22000623-9D8DE6EC-65F8-4A86-912D-094D72B00888 Q26770774-90CCAB3A-2080-411F-B2F8-6A3031636017 Q26786113-00633912-8798-4B1A-AEAE-7FA036F6323E Q26827114-F646CAB6-2FA2-4C79-B5AE-D2A88826C09A Q27025042-93F905FD-A534-4933-AA12-F082D4C1B44D Q28072253-3F648E39-CDFC-4DB7-B22D-F2E997532B53 Q28079666-1842A564-5305-479D-B7D5-C3DEC068B6FF Q28264405-C139744F-295C-462C-AEB4-849C21ACEFC6 Q30386799-D4B13045-33C1-42B2-80EF-C103763CD481 Q30389491-34E18EAC-98C3-4B47-850E-80BAFE8BAF89 Q30540036-8A21FBD3-3750-4716-9D3A-1CFA5B0676C3 Q33827943-12A0B5CB-6029-4234-B82F-DCA6D95F6CEF Q34034549-828090B9-9267-4959-8232-71A7AE467B35 Q34088519-ADE64CFD-FF08-4EF7-8329-AFCAD31AF8E2 Q34263857-241A56F5-6E5B-43CD-96F0-9AF34D1AFB21 Q34481818-1D8971EB-E097-4751-B221-4F4E1E4B79E1 Q35090428-94104DC9-F7AF-4E27-BFC1-C420DF55AF0E Q35646721-496F67F6-C3D2-40D6-8198-701813E3CF6F Q35866112-E7B979DF-FE1B-47EC-8BC4-DB5D0753935F Q36812520-1970FB5A-0B78-483F-BE1D-CD37A2FEE8D0 Q36879898-0FFCCB3D-6E5C-4766-B62D-13F5F40759D7 Q36993609-4309601C-2220-44C5-9AFE-3C2FD3D35F1A Q37032830-ABFD299D-C291-49A3-81C4-D8BCBFB662FB Q37052800-FBE36F3C-745A-452D-AC80-80B18A02A85B Q37179065-BB90483B-5B6E-48CF-91A5-FC305BAEB2F2 Q37250508-72689245-3A72-4CD8-9041-AF8D41669CF4 Q37888959-3BDF7BA3-8486-4F52-896B-DAF50F031343 Q37936924-39B814C1-B44F-487E-9223-BA1FF7DA1860 Q37951805-696FB481-A61D-4399-ABD5-09101C697717 Q38020957-10A7A1D0-DB4E-4BD8-AF51-F31E266D4361 Q38020960-3445682F-673B-4275-8931-F18A0F703D9C Q38289691-3E2F0C52-38F1-47A6-B458-4C03C0FA9F52 Q38372235-3BCD7AB6-E1D6-4377-98A2-A68273F1A984 Q38376430-DE650AA5-5463-4807-82A9-A30226BB6DF3 Q38472546-41A59465-6FB1-4087-BED1-4769A3454F36 Q38502532-45899790-2281-46BB-85E7-C063670C8B96 Q38545106-22D35206-0043-435C-BC17-02665EE665CD Q39102143-801DCA8A-B4B3-4B87-904E-89B5C1C6D6E4 Q39180685-20B388A2-7E52-49A2-9ED4-2EC2D1DE6772 Q41821362-114CA044-9355-4E5F-AF5D-7B41034E337B

P2860

Amphiphysin autoimmunity: paraneoplastic accompaniments.

http://www.wikidata.org/entity/Q45130801

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Amphiphysin autoimmunity: paraneoplastic accompaniments.

@en

Amphiphysin autoimmunity: paraneoplastic accompaniments.

@nl

type

label

Amphiphysin autoimmunity: paraneoplastic accompaniments.

@en

Amphiphysin autoimmunity: paraneoplastic accompaniments.

@nl

prefLabel

Amphiphysin autoimmunity: paraneoplastic accompaniments.

@en

Amphiphysin autoimmunity: paraneoplastic accompaniments.

@nl

P1433

Q45130801-E8DAA0AC-0C6B-4744-AA4E-D01057997F12

P1476

Q45130801-1C3E1904-C7F1-4355-8FD4-2BE0266CFAC5

P2093

Q45130801-593AA6F9-4247-457B-8613-6791EB470794

Q45130801-5D1EDE85-B48B-4D06-95AE-49F9145E3855

Q45130801-6387A810-D37F-42ED-9716-DD92452B2BC9

Q45130801-714292CB-26CC-4359-836F-44F8361CDBA2

Q45130801-9992CC86-5791-4C43-ADC8-8992DAB3A52F

Q45130801-E772E551-99D6-4227-921D-543822A86506

Q45130801-E77E69CC-CACA-4489-9D2D-4F50423F31F2

Q45130801-F7F1BB10-8F4C-4FE7-BB11-0BFCE5056FA9

P2860

Q45130801-02D9A32C-10D4-40B6-AAE1-20DD82B07584

Q45130801-42171A75-4898-447B-A96D-9F068876387E

Q45130801-BCB8891A-5E0C-4BF1-AE76-65DFB67CE011

Q45130801-E3A50B78-EA37-43AC-8884-631BFCE0D20D

Q45130801-F87113EB-E561-466D-A1D6-5A3F01E3991F

P304

Q45130801-924BC94C-9831-4A6A-B32B-4E61790AA708

P31

Q45130801-E7F95568-DCB3-4503-9BA9-A8733742538C

P356

Q45130801-2A8B0048-1873-4702-B9F4-1D50F3C51583

P433

Q45130801-186C8DA7-1E5B-48D9-BABC-239560A0D52C

P478

Q45130801-D1C4615D-250E-46E2-B617-0DA1D09E0CF8

P50

Q45130801-0F23C96C-1665-4881-AE12-B6B303E71276

P577

Q45130801-40D1BDAF-2757-4630-ABF6-3AA7164DF482

P698

Q45130801-8FB4498D-6A1E-435D-AA15-D2DFCB9034F1

P356

P1433

Annals of Neurology

P1476

Amphiphysin autoimmunity: paraneoplastic accompaniments.

@en

P2093

Bahram Mokri

http://www.w3.org/2001/XMLSchema#string

Christina L Stephan

http://www.w3.org/2001/XMLSchema#string

Claudia F Lucchinetti

http://www.w3.org/2001/XMLSchema#string

Joseph E Parisi

http://www.w3.org/2001/XMLSchema#string

Kwang-Kuk Kim

http://www.w3.org/2001/XMLSchema#string

Manfred W Kilimann

http://www.w3.org/2001/XMLSchema#string

Sean J Pittock

http://www.w3.org/2001/XMLSchema#string

Vanda A Lennon

http://www.w3.org/2001/XMLSchema#string

P2860

Stiff-man syndrome updated.

Immunization with neuronal nicotinic acetylcholine receptor induces neurological autoimmune disease.

Neuropathology and binding studies in anti-amphiphysin-associated stiff-person syndrome.

Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies.

Paraneoplastic stiff-person syndrome: no tumor progression over 5 years.

P304

96-107

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANA.20529

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P50

Eduardo E Benarroch

P577

2005-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15984030

http://www.w3.org/2001/XMLSchema#string